Thuya occidentalis is used in popular medicine in the treatment of condyloma and has antibacterial action. Red blood cells (RBC) labeled with technetium99m (99mTc) are used for several evaluations in nuclear medicine. This labeling depends on a reducing agent, usually stannous ion. Any drug which alters the labeling of the tracer could be expected to modify the disposition of the radiopharmaceutical. We have evaluated the influence of T occidentalis extract on the labeling of RBC and plasma proteins with 99mTc. Blood was withdrawn and incubated with T occidentalis (0.25; 2.5; 20.5; and 34.1 percent v/v). Stannous chloride (1.2 pg/ml) was added and then 99mTc was added. Plasma (P) and blood cells (BC) were isolated, also precipitated with trichloroacetic acid and soluble (SF) and insoluble fractions (IF) separated. The analysis of the results shows that there is a decrease in radioactivity (from 97.64 to 75.89 percent) in BC with 34.1 percent of the drug. In the labeling process of RBC with 99mTc, the stannous and pertechnetate ions pass through the membrane, so we suggest that the T occidentalis effect can be explained (i) by an inhibition of the transport of these ions, (ii) by damage in membrane, (iii) by competition with the cited ions for the same binding sites, or (iv) by possible generation of reactive oxygen species that could oxidize the stannous ion.
INTRODUCTION
Thuya occidentalis (American arbor vitae) extract is used in popular medicine as expectorant, diuretic, antihelmintic, stimulant, and in rheumatism treatment. It acts on the renal epithelium and has a toxic action in bladder muscles. It is used in the treatment of cystitis and prostatic hypertrophy in senile men and in urinary incontinence in women. As a tincture, it is popularly used as an abortifacient, as an agent for cauterization of papillomas and condylomatous warts [1, 2, 3] . The biological effects of T occidentalis have been studied previously [1, 2, 3, 4] . (99mTc) has been the most utilized radionuclide in clinical nuclear medicine procedures [5, 6, 7] , and it has also been used in basic research [8, 9, 10, 11, 12] . Its wide use in nuclear medicine is due to its optimal physical characteristics (half-life of 6h, gamma ray energy of 140 keV and resulting minimal dose to the patient), convenient availability from a 99Mo/99mTc generator, and negligible environmental impact. Almost all scanning devices currently in use are optimized for detecting the readioactive emission from this radionuclide [5, 6] .
Of the many applications of 99mTc-labeled red blood cells (RBC)e most important is in cardiovascular nuclear medicine, where one tries to image the heart to determine its functional status as a pump, to calculate the left ventricular function by measuring the ejection fractions, and to evaluate wall motion abnormalities. Some other applications are in the detection of gastrointestinal bleeding and in the determination of the RBC mass in patients [5, 6, 13] . If one damages the RBC, one can do selective spleen imaging (since damaged cells are rapidly sequestered by the spleen) [14] . RBC have been labeled with 99mTc for in vitro [6, 14] , in vivo [5, 6, 13] or in vivo/in vitro [5, 6, 15] techniques. The labeling process with 99mTc depends on a reducing agent and stannous ion (Sn) is usually used for this purpose. When whole blood is employed in the labeling of RBC with 99mTc, radioactivity is found in blood cells, however it is also bound to plasma proteins. This labeling process depends on optimal stannous chloride concentration [16, 17, 18, 19, 20] . Stannous and pertechnetate ions cross the RBC membrane, probably by active transport [21] . The radionuclide is mainly bound to the hemoglobin molecule [22, 23, 24] . Several of the cellular labeling steps have been well-characterized. The band-3 anion transport system [17] and calcium channels [16] may be the ways that 99mTc [17] and Sn [16] [5, 25] or the labeling conditions [15, 20, 27, 28] . Therapy with ,B-adrenergic blockers, calcium channel blockers or nitrate may result in normal exercise radionuclide ventriculograms even in the presence of significant coronary artery disease. Thus, the presence of the disease may be missed and/or underestimated [25] .
In this way, an unusual behavior of the radiopharmaceutical could, on occasion, be due to a drug. Nevertheless, there is not a well established in vitro model to study the interaction of therapeutic drugs with radiopharmaceuticals. Thus, we have evaluated the influence of a T occidentalis extract on the labeling of RBC and plasma proteins with Tc-99m using an in vitro technique.
MATERIAL AND METHODS
These experiments were performed without sacrificing the animals. Heparinized whole blood was withdrawn from Wistar rats. Samples of 0.5 ml were incubated with 100 ,ul of different concentrations of a commercial (Laboratorio Simoes LTDA, Rio de Janeiro, Brazil) T occidentalis extract (0.25; 2.5; 20.5; and 34.1 percent v/v) for 1 hr at room temperature. A sample of heparinized whole blood was incubated with saline solution (NaCI, 0.9 percent) as control. Then, 0.5 ml of stannous chloride (1.2 ,ug/ml), as SnCl2.2H20 (Merck, Brazil) was added and the incubation continued for another 1 hr. After this period of time, 99mTc (0.1 ml), as sodium pertechnetate, recently eluted from a 99Mo/99mTc generator (Instituto de Pesquisas Energeticas e Nucleares, Comissao Nacional de Energia Nuclear, Brazil), was added and the incubation continued for another 10 min. These samples were centrifuged and plasma (P) and blood cells (BC) were separated. Samples (20 1) of P and BC were precipitated with 1 ml of trichloroacetic acid (TCA) (5 percent) and soluble (SF) and insoluble fractions (IF) were separated. The radioactivity in P, BC, IF-P, SF-P, IF-BC and SF-BC were determined in a well counter (Clinigamma, gamma counter, LKB, Wallac, Finland). After that, the percent of radioactivity (percent rad) was calculated, as previously described [19, 20] . A statistical analysis (ANOVA test) was employed to compare the experimental data. 
RESULTS

DISCUSSION
Contrary to the numerous theoretical and practical studies of the conventionally used pharmacologically active agents, the data concerning interaction of diagnostic agents, Red blood cell proteins can be labeled with 99mTc, mainly in the J-chain of the hemoglobin molecule [22, 23] . The fixation of this radioactivity seems not to be modified by T occidentalis extract. Another possibility is that there is a blocking of the labeling inside the cells, but the 99mTc (free) could be precipitated with the red blood cell ghost.
The genotoxic effect of another natural product extract (Paullinia cupana) has been associated to the generation of reactive oxygen species [29] that are oxidizing agents. If T occidentalis would be capable of generating reactive oxygen species, these could oxidize the stannous to stannic ion. This action could explain the decrease on the labeling of red blood cells and plasma proteins with 99mTc in the presence of high concentration of T occidentalis extract.
We can conclude that, depending on T occidentalis concentration, the labeling of red blood cells with 99mTc can be decreased, as well as the fixation of radioactivity in plasma proteins, at least, when an in vitro technique to label red blood cells is employed.
